Wegovy
Employer Health Plans Mull Over Coverage of GLP-1 Agonists for Weight Loss
The International Foundation of Employee Benefit Plans published a report about trends in employee coverage of ...
MARCH 18, 2024
Weight Loss Medications Pose New Challenges for Benefit Leaders
With the surge in popularity of the GLP-1 receptor agonists Saxenda and Wegovy, and the recent FDA approval of ...
MARCH 5, 2024
Dangerous Market for Weight-Loss Drugs Grows Online
High demand and short supply of GLP-1 antagonists used to treat diabetes and obesity have led many people desperate ...
DECEMBER 19, 2023
Load more